{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Fisch MJ"],"funding":["NCI NIH HHS"],"pagination":["1980-8"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC3383175"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["30(16)"],"pubmed_abstract":["<h4>Purpose</h4>Pain is prevalent among patients with cancer, yet pain management patterns in outpatient oncology are poorly understood.<h4>Patients and methods</h4>A total of 3,123 ambulatory patients with invasive cancer of the breast, prostate, colon/rectum, or lung were enrolled onto this prospective study regardless of phase of care or stage of disease. At initial assessment and 4 to 5 weeks later, patients completed a 25-item measure of pain, functional interference, and other symptoms. Providers recorded analgesic prescribing. The pain management index was calculated to assess treatment adequacy.<h4>Results</h4>Of the 3,023 patients we identified to be at risk for pain, 2,026 (67%) reported having pain or requiring analgesics at initial assessment; of these 2,026 patients, 670 (33%)"],"journal":["Journal of clinical oncology : official journal of the American Society of Clinical Oncology"],"pubmed_title":["Prospective, observational study of pain and analgesic prescribing in medical oncology outpatients with breast, colorectal, lung, or prostate cancer."],"pmcid":["PMC3383175"],"funding_grant_id":["P30 CA016672","CA17145","U10 CA037403","U10 CA023318","U10 CA017145","R01 CA026582","CA37604","CA23318","CA026582"],"pubmed_authors":["Wagner LI","Mendoza TR","Chang VT","Manola JB","McCaskill-Stevens W","Fisch MJ","Minasian LM","Cella D","Cleeland CS","Weiss M","Lee JW"],"additional_accession":[]},"is_claimable":false,"name":"Prospective, observational study of pain and analgesic prescribing in medical oncology outpatients with breast, colorectal, lung, or prostate cancer.","description":"<h4>Purpose</h4>Pain is prevalent among patients with cancer, yet pain management patterns in outpatient oncology are poorly understood.<h4>Patients and methods</h4>A total of 3,123 ambulatory patients with invasive cancer of the breast, prostate, colon/rectum, or lung were enrolled onto this prospective study regardless of phase of care or stage of disease. At initial assessment and 4 to 5 weeks later, patients completed a 25-item measure of pain, functional interference, and other symptoms. Providers recorded analgesic prescribing. The pain management index was calculated to assess treatment adequacy.<h4>Results</h4>Of the 3,023 patients we identified to be at risk for pain, 2,026 (67%) reported having pain or requiring analgesics at initial assessment; of these 2,026 patients, 670 (33%)","dates":{"release":"2012-01-01T00:00:00Z","publication":"2012 Jun","modification":"2025-04-19T16:40:22.346Z","creation":"2019-03-27T00:54:54Z"},"accession":"S-EPMC3383175","cross_references":{"pubmed":["22508819"],"doi":["10.1200/jco.2011.39.2381","10.1200/JCO.2011.39.2381"]}}